These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27622867)

  • 1. Circulating biomarkers of fibrosis and cardioversion of atrial fibrillation: A prospective, controlled cohort study.
    Begg GA; Lip GY; Plein S; Tayebjee MH
    Clin Biochem; 2017 Jan; 50(1-2):11-15. PubMed ID: 27622867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-cardiac and peripheral levels of biochemical markers of fibrosis in patients undergoing catheter ablation for atrial fibrillation.
    Begg GA; Karim R; Oesterlein T; Graham LN; Hogarth AJ; Page SP; Pepper CB; Rhode K; Lip GYH; Holden AV; Plein S; Tayebjee MH
    Europace; 2017 Dec; 19(12):1944-1950. PubMed ID: 28339804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum galectin-3 level predicts early recurrence following successful direct-current cardioversion in persistent atrial fibrillation patients.
    Gürses KM; Yalçın MU; Koçyiğit D; Canpınar H; Ateş AH; Canpolat U; Yorgun H; Güç D; Aytemir K
    Turk Kardiyol Dern Ars; 2019 Oct; 47(7):564-571. PubMed ID: 31582678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type III procollagen-N-peptide as a predictor of persistent atrial fibrillation recurrence after cardioversion.
    Kawamura M; Munetsugu Y; Kawasaki S; Onishi K; Onuma Y; Kikuchi M; Tanno K; Kobayashi Y
    Europace; 2012 Dec; 14(12):1719-25. PubMed ID: 22622138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left atrial voltage, circulating biomarkers of fibrosis, and atrial fibrillation ablation. A prospective cohort study.
    Begg GA; Karim R; Oesterlein T; Graham LN; Hogarth AJ; Page SP; Pepper CB; Rhode K; Lip GYH; Holden AV; Plein S; Tayebjee MH
    PLoS One; 2018; 13(1):e0189936. PubMed ID: 29293545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monocyte Chemoattractant Protein-1-Induced Protein in Age-Related Atrial Fibrillation and Its Association with Circulating Fibrosis Biomarkers.
    Zhang G; Abuduoufu A; Zhou X; Li Y; Zhang L; Lu Y; Zhang J; Xin Q; Tang BP
    Cardiology; 2019; 142(4):244-249. PubMed ID: 31203274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Right atrial volume is superior to left atrial volume for prediction of atrial fibrillation recurrence after direct current cardioversion.
    Luong C; Thompson DJ; Bennett M; Gin K; Jue J; Barnes ME; Colley P; Tsang TS
    Can J Cardiol; 2015 Jan; 31(1):29-35. PubMed ID: 25547547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of dual external direct current cardioversion for initial cardioversion in atrial fibrillation.
    Gardner MW; Yadava M; Raitt MH; Elman MR; Zarraga IG; MacMurdy KS; Dalouk KA; Jessel PM
    J Cardiovasc Electrophysiol; 2019 Sep; 30(9):1636-1643. PubMed ID: 31111594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collagen Biomarkers and Incidence of New Onset of Atrial Fibrillation in Subjects With No Overt Cardiovascular Disease at Baseline: The Multi-Ethnic Study of Atherosclerosis.
    Duprez DA; Heckbert SR; Alonso A; Gross MD; Ix JH; Kizer JR; Tracy RP; Kronmal R; Jacobs DR
    Circ Arrhythm Electrophysiol; 2018 Oct; 11(10):e006557. PubMed ID: 30354407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of circulating endothelial progenitor cells to the recurrence of atrial fibrillation after successful conversion and maintenance of sinus rhythm.
    Siu CW; Watson T; Lai WH; Lee YK; Chan YH; Ng KM; Lau CP; Lip GY; Tse HF
    Europace; 2010 Apr; 12(4):517-21. PubMed ID: 19951966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of Circulating Type I Collagen-Related Biomarkers Is Associated With Atrial Fibrillation.
    Ravassa S; Ballesteros G; López B; Ramos P; Bragard J; González A; Moreno MU; Querejeta R; Vives E; García-Bolao I; Díez J
    J Am Coll Cardiol; 2019 Apr; 73(12):1398-1410. PubMed ID: 30922470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High molecular weight fibroblast growth factor-2 as a promising prognostic biomarker to predict the occurrence of heart failure in atrial fibrillation patients.
    Sun LY; Qu X; Chen LZ; Chen XX; Zheng GS; Wang ZT; Huang WJ; Zhou H
    Heart Vessels; 2017 Dec; 32(12):1506-1512. PubMed ID: 28689282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrocardiographic markers of cardioversion success in patients with atrial fibrillation.
    Al Aloul B; Adabag AS; Can I; Roukoz H; McClintock S; Benditt D; Tholakanahalli V
    South Med J; 2009 Sep; 102(9):885-9. PubMed ID: 19668022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging, biomarker and invasive assessment of diffuse left ventricular myocardial fibrosis in atrial fibrillation.
    Begg GA; Swoboda PP; Karim R; Oesterlein T; Rhode K; Holden AV; Greenwood JP; Shantsila E; Lip GYH; Plein S; Tayebjee MH
    J Cardiovasc Magn Reson; 2020 Feb; 22(1):13. PubMed ID: 32036784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The change in circulating galectin-3 predicts absence of atrial fibrillation after thoracoscopic surgical ablation.
    Berger WR; Jagu B; van den Berg NWE; Chan Pin Yin DRPP; van Straalen JP; de Boer OJ; Driessen AHG; Neefs J; Krul SPJ; van Boven WP; van der Wal AC; de Groot JR
    Europace; 2018 May; 20(5):764-771. PubMed ID: 28525549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The predictive value of plasma brain natriuretic peptide for the recurrence of atrial fibrillation six months after external cardioversion.
    Ari H; Binici S; Ari S; Akkaya M; Koca V; Bozat T; Gürdoğan M
    Turk Kardiyol Dern Ars; 2008 Oct; 36(7):456-60. PubMed ID: 19155659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of direct current cardioversion for atrial arrhythmia in adult Fontan patients.
    Egbe AC; Connolly HM; Niaz T; McLeod CJ
    Int J Cardiol; 2016 Apr; 208():115-9. PubMed ID: 26849685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of C-reactive protein to long-term risk of recurrence of atrial fibrillation after electrical cardioversion.
    Loricchio ML; Cianfrocca C; Pasceri V; Bianconi L; Auriti A; Calo L; Lamberti F; Castro A; Pandozi C; Palamara A; Santini M
    Am J Cardiol; 2007 May; 99(10):1421-4. PubMed ID: 17493472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of biomarkers of inflammation and extracellular matrix turnover on the outcome of atrial fibrillation ablation: importance of matrix metalloproteinase-2 as a predictor of atrial fibrillation recurrence.
    Okumura Y; Watanabe I; Nakai T; Ohkubo K; Kofune T; Kofune M; Nagashima K; Mano H; Sonoda K; Kasamaki Y; Hirayama A
    J Cardiovasc Electrophysiol; 2011 Sep; 22(9):987-93. PubMed ID: 21489023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum amyloid a and C-reactive protein independently predict the recurrences of atrial fibrillation after cardioversion in patients with preserved left ventricular function.
    Barassi A; Pezzilli R; Morselli-Labate AM; Lombardi F; Belletti S; Dogliotti G; Corsi MM; Merlini G; Melzi d'Eril GV
    Can J Cardiol; 2012; 28(5):537-41. PubMed ID: 22552174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.